Veale, Emma L., Al-Moubarak, Ehab, Bajaria, Naina, Omoto, Kiyoyuki, Cao, Lishuang, Tucker, Stephen J., Stevens, Edward B., Mathie, Alistair (2014) Influence of the N terminus on the Biophysical Properties and Pharmacology of TREK1 Potassium Channels. Molecular Pharmacology, 85 (5). pp. 671-681. ISSN 0026-895X. E-ISSN 1521-0111. (doi:10.1124/mol.113.091199) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:38616)
The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
Official URL: http://dx.doi.org/10.1124/mol.113.091199 |
Abstract
TWIK-related K+ 1 (TREK1) potassium channels are members of the two-pore domain potassium channel family and contribute to background potassium conductances in many cell types, where their activity can be regulated by a variety of physiologic and pharmacologic mediators. Fenamates such as FFA (flufenamic acid; 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid), MFA [mefenamic acid; 2-(2,3-dimethylphenyl)aminobenzoic acid], NFA [niflumic acid; 2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid], and diclofenac [2-(2-(2,6-dichlorophenylamino)phenyl)acetic acid] and the related experimental drug BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine] enhance the activity of TREK1 currents, and we show that BL-1249 is the most potent of these compounds. Alternative translation initiation produces a shorter, N terminus truncated form of TREK1 with a much reduced open probability and a proposed increased permeability to sodium compared with the longer form. We show that both forms of TREK1 can be activated by fenamates and that a number of mutations that affect TREK1 channel gating occlude the action of fenamates but only in the longer form of TREK1. Furthermore, fenamates produce a marked enhancement of current through the shorter, truncated form of TREK1 and reveal a K+-selective channel, like the long form. These results provide insight into the mechanism of TREK1 channel activation by fenamates, and, given the role of TREK1 channels in pain, they suggest a novel analgesic mechanism for these compounds.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1124/mol.113.091199 |
Subjects: | Q Science > QP Physiology (Living systems) |
Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
Depositing User: | Alistair Mathie |
Date Deposited: | 06 Mar 2014 16:39 UTC |
Last Modified: | 17 Aug 2022 10:56 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/38616 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):